PMID: 18719317Aug 23, 2008Paper

Diazepam protects against the enhanced toxicity of cocaine adulterated with atropine

Journal of Pharmacological Sciences
Daniela BraidaMariaelvina Sala

Abstract

We examined the toxicity of cocatropine (cocaine/atropine mixture) and the therapeutic potential of diazepam on some behavioral and physiological parameters in rats. Atropine (20 and 60 mg/kg) or cocaine (40 mg/kg) alone did not induce any seizure or death, but the combination significantly increased both, after both acute and binge treatment. There was a significant increase of EEG mean total spectral power in cocatropine- in comparison with cocaine-treated animals. Hyperlocomotion was observed in non-seizuring rats treated with cocaine or cocatropine. Cocaine, atropine 60, and cocatropine (40 + 20 and 40 + 60) all induced hyperthermic effects in non-seizuring rats, while cocatropine (40 + 60)-seizuring animals had hypothermia. An initial hypertensive and tachycardiac effect within 15 min was followed by a secondary fall in the cocatropine (40 + 60) group. Cocatropine toxicity was partially or fully reversed by diazepam (5 mg/kg), given intraperitoneally after the first seizure. The present findings provide, for the first time, details of a synergistic toxic effect of the cocaine/atropine mixture and of the potential of diazepam for treating cocatropine-related hospital emergencies.

References

Mar 1, 1991·Drug and Alcohol Dependence·S NoguéR de la Torre
Jan 1, 1989·Life Sciences·J M WitkinM J Kuhar
May 1, 1989·Annals of Emergency Medicine·R W Derlet, T E Albertson
Jul 1, 1988·Drug Intelligence & Clinical Pharmacy·C M QuandtM H McCallum
Feb 1, 1987·Annals of Emergency Medicine·W SilversteinL Goldfrank
Dec 1, 1980·Journal of Neuroscience Methods·G PaxinosP C Emson
Apr 1, 1984·Biulleten' eksperimental'noĭ biologii i meditsiny·I N MoiseevL S Godlevskiĭ
Oct 1, 1982·Annals of Emergency Medicine·G R Gay
Feb 1, 1980·Journal of Comparative and Physiological Psychology·T SchallertP Teitelbaum
Jan 1, 1982·Anesthesia and Analgesia·R H de JongR A DeRosa
Jul 1, 1981·Pharmacology, Biochemistry, and Behavior·C E Johanson, T Aigner
Jun 1, 1980·Clinical Toxicology·M M GuinnM C Wilson
Sep 1, 1993·Pharmacology, Biochemistry, and Behavior·C C TsengT E Albertson
Sep 1, 1996·Epilepsia·B S KoppelM Daras
Jan 24, 1998·Brain Research·J H YeJ J McArdle
Sep 3, 1998·The American Journal of Emergency Medicine·A L WeinerE Starr
Oct 7, 1998·Neurotoxicology and Teratology·G D CapponC V Vorhees
Aug 24, 1999·European Journal of Pharmacology·G R HansonH S White
Aug 6, 2000·British Journal of Anaesthesia·J A Henry
Dec 9, 2000·Naunyn-Schmiedeberg's Archives of Pharmacology·B ShiA D Kaye
Nov 13, 2001·Journal of Clinical Anesthesia·T MatsukawaT Kumazawa
Sep 10, 2002·Anesthesiology·Robert A WhittingtonHisayo O Morishima
May 22, 2003·Neurotoxicology and Teratology·Gregory D Busse, Anthony L Riley
Aug 26, 2004·The Journal of Pharmacology and Experimental Therapeutics·Jerry J BuccafuscoMahanandeeshwar Gattu
Oct 7, 2004·European Journal of Pharmacology·Anthony S BasilePhil Skolnick
Aug 11, 2005·Journal of Applied Toxicology : JAT·Leena PradhanPhilip J Kadowitz
Feb 19, 2008·Critical Care : the Official Journal of the Critical Care Forum·Robert J Devlin, John A Henry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.